- Home
- NVGS vs SPRY Comparison
NVGS vs SPRY Comparison
Compare NVGS & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVGS | SPRY |
|---|---|---|
| Founded | 1997 | 2015 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NVGS | SPRY |
|---|---|---|
| Price | $18.02 | $10.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $21.50 | ★ $31.25 |
| AVG Volume (30 Days) | 272.8K | ★ 1.6M |
| Earning Date | 11-04-2025 | 11-10-2025 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | ★ 33.99 | N/A |
| EPS | ★ 1.50 | N/A |
| Revenue | ★ $578,158,000.00 | $142,772,000.00 |
| Revenue This Year | $2.77 | N/A |
| Revenue Next Year | N/A | $127.81 |
| P/E Ratio | $12.33 | ★ N/A |
| Revenue Growth | 2.46 | ★ 5459.66 |
| 52 Week Low | $10.55 | $6.66 |
| 52 Week High | $18.51 | $18.90 |
Technical Indicators
Market Signals| Indicator | NVGS | SPRY |
|---|---|---|
| Relative Strength Index (RSI) | 58.91 | 55.38 |
| Support Level | $17.13 | $10.85 |
| Resistance Level | $17.40 | $11.43 |
| Average True Range (ATR) | 0.33 | 0.60 |
| MACD | 0.08 | -0.07 |
| Stochastic Oscillator | 51.59 | 57.47 |
Price Performance
Historical ComparisonAbout NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Company play a vital role in theglobalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users and commodity traders.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.